ESOR Galen Advanced Course on Oncologic Imaging

May 25th, 2016May 26th, 2016
London, --
GB
http://www.esor.org/cms/website.php?id=/en/programmes/galen_advanced_courses/oncologic_imaging.htm
This course is aimed at senior residents and recently certified radiologists interested in oncologic imaging.
Latest in Home
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
July 1, 2026
Patient Cancer Doctor 400 (1)
Most patients want to know if AI being used for imaging reports
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
Low muscle density on coronary CT linked to heart risk
June 30, 2026
AI adoption is growing across UK imaging and cancer services, but workforce shortages persist-
More work than relief: AI in the wrong seat, RCR census finds
June 29, 2026
More in Home
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
By Claudia Tschabuschnig
Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.
July 1, 2026
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.
Most patients want to know if AI being used for imaging reports
By Amerigo Allegretto
Most patients want disclosure about whether AI is being used for their imaging reports.
June 30, 2026
Patient Cancer Doctor 400 (1)
Low muscle density on coronary CT linked to heart risk
By Will Morton
Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
More work than relief: AI in the wrong seat, RCR census finds
By Claudia Tschabuschnig
AI adoption is climbing fast across U.K. radiology and cancer services, but put in the wrong room, it creates more noise than signal.
June 29, 2026
AI adoption is growing across UK imaging and cancer services, but workforce shortages persist-
U.K. radiologist staffing lags EU peers, RCR census shows
By Claudia Tschabuschnig
A growing shortage of radiologists, surging imaging demand, and mounting reliance on costly temporary staffing are placing increasing pressure on U.K. imaging services, according to the Royal College of Radiologists' latest workforce census.
June 25, 2026
The 2025 census report from the Royal College of Radiologists highlights the challenges facing services across the UK.
PET/CT could improve margin assessment for breast tumors
By Amerigo Allegretto
Specimen PET/CT imaging outperforms routine intraoperative margin assessment in breast tumors.
June 19, 2026
Pet Scan Patient 400 (1)
One conference, three lessons
By Dr. Giles Maskell
Sharing mistakes can be an important learning experience for radiologists, according to a new column from Dr. Giles Maskell.
June 18, 2026
Maskell Giles 2020 400
Single-fraction SBRT a valid option for localized prostate cancer
By Will Morton
Estimated three-year biochemical relapse-free survival was 92.9%.
June 18, 2026
Prostate Imaging
WHO: Europe's healthcare systems face "permacrisis"
By Claudia Tschabuschnig
Overlapping shortages, an aging population, and a workforce "voting with its feet" -- "permacrisis," that's how WHO Europe described the state of healthcare on the continent at the inaugural UEMS Congress in Leuven.
June 18, 2026
'We are no longer preparing for crises. We are actively navigating an era of permanent, overlapping disruptions, the convergence of rapid climate change, demographic shifts, systemic economic uncertainty, and a critical healthcare workforce means that traditional boundaries of healthcare are obsolete,' says Pavlos Theodorakis, senior health policy advisor at the WHO European Office.
German MRI concept aims to transform pediatric imaging
By Claudia Tschabuschnig
Why pediatric MRI still means anesthesia for too many children and how the field is trying to change that.
June 17, 2026
As part of the KidsMRI project, children are to be introduced to the examination using age-appropriate training and support concepts, with the aim of enabling MRI scans to be performed more often without anesthesia in the future.
Video: Dr. Alba Pugliesi on what keeps her dreams big
By Claudia Tschabuschnig
In a video interview, radiologist Dr. Rosa Alba Pugliesi shares how limits are only in your head.
June 16, 2026
Dr. Alba Pugliesi
UEMS: Ukraine health leaders: Resiliency should never mean isolation
By Claudia Tschabuschnig
Bomb shelters, blackouts, and exceptional growth: some of Ukraine's leading voices in healthcare spoke at the UEMS Congress to argue that a wartime healthcare system isn't just a cause for solidarity, but a working model Europe will need.
June 15, 2026
Firefighters in Kyiv inspect a damaged building after an attack, illustrating the destruction wrought by the war.
Page 1 of 86
Next Page